Mounjaro on the NHS in England: What’s New in 2026

The NHS is rolling out Mounjaro access in phases, prioritising adults considered to be at the highest clinical risk due to their weight. During the initial period, availability will be limited primarily to those with the highest clinical need.
Initial NHS access typically prioritises:

Initial NHS access typically prioritises:

1. Adults with a Body Mass Index (BMI) of 40 kg/m² or higher plus at least one weight-related health problem, including:

• dyslipidaemia (abnormal fat levels in the blood)
• hypertension (high blood pressure)
• obstructive sleep apnoea (when your breathing stops and starts while you sleep)
• cardiovascular disease (heart and blood vessel disease)
• type 2 diabetes mellitus

2. Adults from specific ethnic backgrounds (including South Asian, Chinese, Black African, and African-Caribbean) may be eligible with a lower BMI threshold, often 37.5 kg/m² or higher, due to increased health risks at lower BMIs.

Access is not guaranteed immediately. Prescribing (especially by GPs) is conditional on these wraparound services being commissioned and available locally. Check with your local Integrated Care Board (ICB) for availability in your area.

First, speak to your GP. They can assess your situation and determine whether you might meet the NHS criteria for Mounjaro or be referred to a specialist weight management service.

Preparing for Your GP Appointment

Before your visit, make sure you can give the doctor the following:

• Your current weight and height (allowing calculation of your BMI).
• Results of any recent blood tests, particularly your HbA1c level if you have type 2 diabetes.
• Previous medications tried for diabetes or weight management.
• Details of lifestyle changes you have already made (e.g., diet, exercise).
• Any questions you have about Mounjaro or alternative treatments?
• Providing this information helps your doctor better understand your situation.

What Your GP Will Consider Before Prescribing?

Your doctor will check:

• Your BMI, considering any adjustments for ethnic background.
• Any existing weight-related health conditions.
• Your blood sugar control, if you have type 2 diabetes (your HbA1c score).
• Your history of attempts at weight loss through lifestyle changes

Based on this assessment and local service availability, your GP may be able to prescribe Mounjaro (if wraparound care is in place) or refer you to a specialist weight management service.

Summary on Mounjaro On the NHS in England

From March 2025, Mounjaro became available via specialist weight management clinics on the NHS. These services offer comprehensive support from multidisciplinary teams.

The NHS rollout is gradual. Initially, access (including potential GP prescribing, where available) may prioritise individuals most in need – typically those with a BMI of 40 kg/m² or above (with adjustments for specific ethnic backgrounds) and at least one serious weight-related health condition. If you are eligible for NHS treatment, you will also receive “wraparound care,” providing essential support with diet, physical activity, and lifestyle changes alongside the medication.

This careful, phased approach ensures safety, allows time for service development, and prioritises access for those with the greatest clinical need. NICE plans to review the implementation and potentially widen access after an initial period (likely around three years).

To find out if you might qualify and what services are available locally, the best approach is to speak to your GP and check with your local Integrated Care Board (ICB).

Additionally, it's important to note: Mounjaro holds a separate license and may be prescribed on the NHS for managing type 2 diabetes under different criteria. Full details can be found on the NICE website.

What are the NHS requirements to get Mounjaro for weight loss?

According to the new NHS guidelines, you’ll need to meet these requirements:

1. Have a BMI of 40 or more.
2. Also have at least four weight-related health conditions (such as type 2 diabetes, heart problems, sleep apnoea, etc.)
3. Have access to wraparound care facilities in your area (such as regular check-ups, dietary advice, and support with lifestyle changes).

Can You Get Mounjaro Privately in the UK?

Yes, Mounjaro is available on private prescription in the UK from registered clinics and licensed online pharmacies (such as Ashcroft Pharmacy) for individuals who meet the clinical eligibility criteria but either do not qualify for NHS treatment or choose not to wait. Private treatment involves paying the full cost of the medication and consultation fees.

Private Mounjaro Treatment Costs in the UK

"At Ashcroft Pharmacy, our private Mounjaro service starts at £149.99 for the 2.5mg starting dose, with prices ranging up to £294.99 for the highest dose.

This price includes your medication and all the necessary supplies for your treatment: needles, alcohol wipes, and a sharps bin.

Delivery charges are separate and will depend on the shipping option you select at checkout. Next-day delivery options may have an additional cost.

Safety Tips for Buying Mounjaro Privately in the UK

To stay safe:

• Use clinics registered with the Care Quality Commission (CQC).
• Avoid sellers without prescriptions. 
• Have your doctor or pharmacist check it.
• Watch out for prices much lower than normal, they may be fake.
• Get a medical check before starting Mounjaro.

Use trusted sources to protect your health and get genuine medicine.

https://www.england.nhs.uk/wp-content/uploads/2025/03/PRN01879-interim-commissioning-guidance-implementation-of-the-nice-technology-appraisal-ta1026-and-the-NICE-fu.pdf [Accessed  on 17 July 2025]

https://www.nice.org.uk/guidance/ta1026 [Accessed on 18 July 2025]

https://www.poundhillmedicalgroup.co.uk/2025/06/06/gps-prescribing-mounjaro/ [Accessed 18 July 2025]

https://www.newcrosshc.co.uk/news/mounjaro-and-weight-loss  [Accessed on 18 July 2025]

https://www.gov.uk/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss [Accessed on 18 July 2025]